Anthony Louder

529 total citations
17 papers, 353 citations indexed

About

Anthony Louder is a scholar working on Family Practice, Economics and Econometrics and Surgery. According to data from OpenAlex, Anthony Louder has authored 17 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Family Practice, 4 papers in Economics and Econometrics and 3 papers in Surgery. Recurrent topics in Anthony Louder's work include Medication Adherence and Compliance (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Diabetes Treatment and Management (3 papers). Anthony Louder is often cited by papers focused on Medication Adherence and Compliance (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Diabetes Treatment and Management (3 papers). Anthony Louder collaborates with scholars based in United States, Sweden and Germany. Anthony Louder's co-authors include Raymond Jang, Robert J. Cluxton, Jeff J. Guo, Lisa M. Hess, Ana B. Oton, Katherine B. Winfree, Yajun Emily Zhu, Radhika Nair, Karen Worley and John Graham and has published in prestigious journals such as Gastroenterology, Value in Health and BMC Musculoskeletal Disorders.

In The Last Decade

Anthony Louder

17 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony Louder United States	11	72	72	69	56	42	17	353
Julie Couture Canada	12	68 0.9×	49 0.7×	98 1.4×	70 1.3×	42 1.0×	20	378
Przemysław Holko Poland	12	38 0.5×	48 0.7×	52 0.8×	63 1.1×	24 0.6×	33	358
Vishvas Garg United States	13	120 1.7×	65 0.9×	27 0.4×	52 0.9×	14 0.3×	48	469
Arielle G. Bensimon United States	12	48 0.7×	123 1.7×	31 0.4×	73 1.3×	43 1.0×	34	543
Joshua Posner United States	11	20 0.3×	104 1.4×	21 0.3×	55 1.0×	24 0.6×	24	326
Rajeshwari Punekar United States	10	34 0.5×	110 1.5×	24 0.3×	78 1.4×	8 0.2×	20	319
Brian Bekker Hansen Denmark	13	95 1.3×	32 0.4×	118 1.7×	20 0.4×	7 0.2×	20	441
Mirza I. Rahman United States	10	92 1.3×	41 0.6×	15 0.2×	43 0.8×	10 0.2×	18	379
Linda Labberton Sweden	7	25 0.3×	34 0.5×	61 0.9×	21 0.4×	25 0.6×	8	443
David T. Myers United States	6	10 0.1×	34 0.5×	114 1.7×	68 1.2×	11 0.3×	13	388

Countries citing papers authored by Anthony Louder

Since Specialization

Citations

This map shows the geographic impact of Anthony Louder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Louder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Louder more than expected).

Fields of papers citing papers by Anthony Louder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Louder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Louder. The network helps show where Anthony Louder may publish in the future.

Co-authorship network of co-authors of Anthony Louder

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Louder. A scholar is included among the top collaborators of Anthony Louder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Louder. Anthony Louder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Jaksa, Ashley, Anthony Louder, Laura Díaz‐Martín, et al.. (2022). A Comparison of 7 Oncology External Control Arm Case Studies: Critiques From Regulatory and Health Technology Assessment Agencies. Value in Health. 25(12). 1967–1976. 28 indexed citations

2.

Skornicki, Michelle, et al.. (2021). Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis. Advances in Therapy. 38(5). 2458–2471. 8 indexed citations

3.

Chapman, Jonathan, Marco DiBonaventura, Anthony Louder, et al.. (2019). P068 EXTRAINTESTINAL MANIFESTATIONS AND THEIR IMPACT ON REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH ULCERATIVE COLITIS. Gastroenterology. 156(3). S47–S48. 2 indexed citations

4.

Hess, Lisa M., Anthony Louder, Katherine B. Winfree, et al.. (2017). Factors Associated with Adherence to and Treatment Duration of Erlotinib Among Patients with Non-Small Cell Lung Cancer. Journal of Managed Care & Specialty Pharmacy. 23(6). 643–652. 35 indexed citations

5.

Peng, Xiaomei, Haoda Fu, Haya Ascher‐Svanum, et al.. (2016). Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs. Journal of Managed Care & Specialty Pharmacy. 22(5). 467–482. 11 indexed citations

6.

Louder, Anthony. (2016). Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma.. PubMed. 9(2). 84–7. 140 indexed citations

7.

Louder, Anthony, Kim Saverno, Gregory L. Smith, et al.. (2016). Molecular testing patterns in metastatic non-small cell lung cancer.. PubMed. 22(2). e60–7. 18 indexed citations

8.

Peng, Xiaomei, Haoda Fu, Haya Ascher‐Svanum, et al.. (2016). Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs. Journal of Managed Care & Specialty Pharmacy. 1–16. 4 indexed citations

9.

Pasquale, Margaret K., et al.. (2015). Healthcare Utilization and Costs of Knee or Hip Replacements versus Pain-Relief Injections.. PubMed. 8(7). 384–94. 11 indexed citations

10.

Schwab, Phil, Anthony Louder, Yong Li, Rajiv Mallick, & Harold Bays. (2014). Cholesterol Treatment Patterns and Cardiovascular Clinical Outcomes Associated with Colesevelam HCl and Ezetimibe. Drugs & Aging. 31(9). 683–694. 3 indexed citations

11.

Hazel‐Fernandez, Leslie, et al.. (2013). Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study. BMC Musculoskeletal Disorders. 14(1). 4–4. 13 indexed citations

12.

Worley, Karen, et al.. (2013). Retrospective Database Analysis of the Impact of Prior Authorization for Type 2 Diabetes Medications on Health Care Costs in a Medicare Advantage Prescription Drug Plan Population. Journal of Managed Care Pharmacy. 19(5). 374–384. 24 indexed citations

13.

Udall, Margarita, Anthony Louder, Brandon T. Suehs, et al.. (2013). Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population. Journal of Medical Economics. 16(6). 784–792. 10 indexed citations

14.

Pasquale, Margaret K., et al.. (2013). Out-of-pocket costs and prescription reversals with oral linezolid.. PubMed. 19(9). 734–40. 4 indexed citations

15.

Suehs, Brandon T., Anthony Louder, Margarita Udall, et al.. (2013). Impact of a Pregabalin Step Therapy Policy Among Medicare Advantage Beneficiaries. Pain Practice. 14(5). 419–426. 13 indexed citations

16.

Alpert, Joseph S., et al.. (2012). Impact of certified CME in atrial fibrillation on administrative claims.. PubMed. 18(5). 253–60. 2 indexed citations

17.

Guo, Jeff J., Raymond Jang, Anthony Louder, & Robert J. Cluxton. (2005). Acute Pancreatitis Associated with Different Combination Therapies in Patients Infected with Human Immunodeficiency Virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(8). 1044–1054. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact